These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


107 related items for PubMed ID: 3007372

  • 1. Comparison of risk factors for cervical cancer in different populations.
    Rawls WE, Lavery C, Marrett LD, Clarke EA, Adam E, Melnick JL, Best JM, Kraiselburd E, Benedet LJ, Brenes MM.
    Int J Cancer; 1986 Apr 15; 37(4):537-46. PubMed ID: 3007372
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Herpes simplex virus-2 as a human papillomavirus cofactor in the etiology of invasive cervical cancer.
    Smith JS, Herrero R, Bosetti C, Muñoz N, Bosch FX, Eluf-Neto J, Castellsagué X, Meijer CJ, Van den Brule AJ, Franceschi S, Ashley R, International Agency for Research on Cancer (IARC) Multicentric Cervical Cancer Study Group.
    J Natl Cancer Inst; 2002 Nov 06; 94(21):1604-13. PubMed ID: 12419786
    [Abstract] [Full Text] [Related]

  • 4. Case control study of cervical cancer in Herrera Province, Republic of Panama.
    Reeves WC, Brinton LA, Brenes MM, Quiroz E, Rawls WE, De Britton RC.
    Int J Cancer; 1985 Jul 15; 36(1):55-60. PubMed ID: 4040497
    [Abstract] [Full Text] [Related]

  • 5. Sex partners and herpes simplex virus type 2 in the epidemiology of cancer of the cervix.
    Graham S, Rawls W, Swanson M, McCurtis J.
    Am J Epidemiol; 1982 May 15; 115(5):729-35. PubMed ID: 6282116
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. [Serum HSV-2 antibody in males from high and low incidence areas of cervical cancer].
    Chen WK, Cheng L, Guo SF, Xiang JM.
    Zhonghua Zhong Liu Za Zhi; 1986 May 15; 8(3):199-200. PubMed ID: 3017663
    [Abstract] [Full Text] [Related]

  • 8. Antibodies to Herpes simplex virus types 1 and 2 in patients with squamous-cell carcinoma of uterine cervix in India.
    Seth P, Prakash SS, Ghosh D.
    Int J Cancer; 1978 Dec 15; 22(6):708-14. PubMed ID: 214407
    [Abstract] [Full Text] [Related]

  • 9. Human papillomaviruses and other influences on survival from cervical cancer in Panama.
    DeBritton RC, Hildesheim A, De Lao SL, Brinton LA, Sathya P, Reeves WC.
    Obstet Gynecol; 1993 Jan 15; 81(1):19-24. PubMed ID: 8380103
    [Abstract] [Full Text] [Related]

  • 10. A prospective study of association of herpes simplex virus and human papillomavirus infection with cervical neoplasia in women exposed to diethylstilbestrol in utero.
    Adam E, Kaufman RH, Adler-Storthz K, Melnick JL, Dreesman GR.
    Int J Cancer; 1985 Jan 15; 35(1):19-26. PubMed ID: 2981778
    [Abstract] [Full Text] [Related]

  • 11. Herpes simplex virus type 2 and human papillomavirus type 16 in cervicitis, dysplasia and invasive cervical carcinoma.
    Prakash SS, Reeves WC, Sisson GR, Brenes M, Godoy J, Bacchetti S, de Britton RC, Rawls WE.
    Int J Cancer; 1985 Jan 15; 35(1):51-7. PubMed ID: 2981783
    [Abstract] [Full Text] [Related]

  • 12. Chlamydia trachomatis and cervical neoplasia.
    Schachter J, Hill EC, King EB, Heilbron DC, Ray RM, Margolis AJ, Greenwood SA.
    JAMA; 1982 Nov 05; 248(17):2134-8. PubMed ID: 6288978
    [Abstract] [Full Text] [Related]

  • 13. Human papillomavirus, herpes simplex virus and cervical cancer incidence in Greenland and Denmark. A population-based cross-sectional study.
    Kjaer SK, de Villiers EM, Haugaard BJ, Christensen RB, Teisen C, Møller KA, Poll P, Jensen H, Vestergaard BF, Lynge E.
    Int J Cancer; 1988 Apr 15; 41(4):518-24. PubMed ID: 2833450
    [Abstract] [Full Text] [Related]

  • 14. HSV-IgA serum antibodies in cervical intraepithelial neoplasia and invasive cancer patients, and in their spouses: a case control study.
    Gupta MM, Jain R, Parashari A, Singh V, Satyanarayana L.
    APMIS; 1992 Jul 15; 100(7):598-604. PubMed ID: 1322678
    [Abstract] [Full Text] [Related]

  • 15. Class-specific herpes simplex virus antibodies in sera and cervical secretions from patients with cervical neoplasia: a multi-group comparison.
    Dale GE, Coleman RM, Best JM, Benetato BB, Drew NC, Chinn S, Papacosta AO, Nahmias AJ.
    Epidemiol Infect; 1988 Jun 15; 100(3):445-65. PubMed ID: 2837405
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Herpes simplex virus type 2: a possible interaction with human papillomavirus types 16/18 in the development of invasive cervical cancer.
    Hildesheim A, Mann V, Brinton LA, Szklo M, Reeves WC, Rawls WE.
    Int J Cancer; 1991 Sep 30; 49(3):335-40. PubMed ID: 1655658
    [Abstract] [Full Text] [Related]

  • 19. Herpesvirus infection and cervical anaplasia: a seroepidemiological study.
    Choi NW, Shettigara PT, Abu-Zeid HA, Nelson NA.
    Int J Cancer; 1977 Feb 15; 19(2):167-71. PubMed ID: 190174
    [Abstract] [Full Text] [Related]

  • 20. Risk factors for cervical neoplasia in Denmark.
    Kjaer SK.
    APMIS Suppl; 1998 Feb 15; 80():1-41. PubMed ID: 9693662
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 6.